993 related articles for article (PubMed ID: 21677094)
41. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
Newmeyer MN; Swortwood MJ; Barnes AJ; Abulseoud OA; Scheidweiler KB; Huestis MA
Clin Chem; 2016 Dec; 62(12):1579-1592. PubMed ID: 27899456
[TBL] [Abstract][Full Text] [Related]
42. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.
Milman G; Bergamaschi MM; Lee D; Mendu DR; Barnes AJ; Vandrey R; Huestis MA
Ther Drug Monit; 2014 Apr; 36(2):218-24. PubMed ID: 24067260
[TBL] [Abstract][Full Text] [Related]
43. Simultaneous quantification of THC-COOH, OH-THC, and further cannabinoids in human hair by gas chromatography-tandem mass spectrometry with electron ionization applying automated sample preparation.
Kieliba T; Lerch O; Andresen-Streichert H; Rothschild MA; Beike J
Drug Test Anal; 2019 Feb; 11(2):267-278. PubMed ID: 30144294
[TBL] [Abstract][Full Text] [Related]
44. Cannabis Use Surveillance by Sweat Analysis.
Gambelunghe C; Fucci N; Aroni K; Bacci M; Marcelli A; Rossi R
Ther Drug Monit; 2016 Oct; 38(5):634-9. PubMed ID: 27465974
[TBL] [Abstract][Full Text] [Related]
45. Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips.
Andersson M; Scheidweiler KB; Sempio C; Barnes AJ; Huestis MA
Anal Bioanal Chem; 2016 Sep; 408(23):6461-71. PubMed ID: 27422645
[TBL] [Abstract][Full Text] [Related]
46. Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users.
Sholler DJ; Zamarripa CA; Spindle TR; Martin EL; Kuntz D; Vandrey R; Grabenauer M
J Anal Toxicol; 2022 Oct; 46(8):882-890. PubMed ID: 35770374
[TBL] [Abstract][Full Text] [Related]
47. Cannabinoids in exhaled breath following controlled administration of smoked cannabis.
Himes SK; Scheidweiler KB; Beck O; Gorelick DA; Desrosiers NA; Huestis MA
Clin Chem; 2013 Dec; 59(12):1780-9. PubMed ID: 24046200
[TBL] [Abstract][Full Text] [Related]
48. Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure.
Lowe RH; Abraham TT; Darwin WD; Herning R; Cadet JL; Huestis MA
Drug Alcohol Depend; 2009 Nov; 105(1-2):24-32. PubMed ID: 19631478
[TBL] [Abstract][Full Text] [Related]
49. Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.
Nadulski T; Sporkert F; Schnelle M; Stadelmann AM; Roser P; Schefter T; Pragst F
J Anal Toxicol; 2005; 29(8):782-9. PubMed ID: 16356335
[TBL] [Abstract][Full Text] [Related]
50. Cannabinoids in hair: strategy to prove marijuana/hashish consumption.
Uhl M; Sachs H
Forensic Sci Int; 2004 Oct; 145(2-3):143-7. PubMed ID: 15451086
[TBL] [Abstract][Full Text] [Related]
51. Determination of cannabinoids in urine, oral fluid and hair samples after repeated intake of CBD-rich cannabis by smoking.
Gerace E; Bakanova SP; Di Corcia D; Salomone A; Vincenti M
Forensic Sci Int; 2021 Jan; 318():110561. PubMed ID: 33172758
[TBL] [Abstract][Full Text] [Related]
52. Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.
Karschner EL; Schwilke EW; Lowe RH; Darwin WD; Herning RI; Cadet JL; Huestis MA
J Anal Toxicol; 2009 Oct; 33(8):469-77. PubMed ID: 19874654
[TBL] [Abstract][Full Text] [Related]
53. Kinetics of CBD, Δ
Jaidee W; Siridechakorn I; Nessopa S; Wisuitiprot V; Chaiwangrach N; Ingkaninan K; Waranuch N
Cannabis Cannabinoid Res; 2022 Aug; 7(4):537-547. PubMed ID: 34096805
[No Abstract] [Full Text] [Related]
54. An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina.
Fernández N; Cappello MG; Quiroga PN
Forensic Sci Int; 2023 Aug; 349():111762. PubMed ID: 37392612
[TBL] [Abstract][Full Text] [Related]
55. THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis".
Pacifici R; Pichini S; Pellegrini M; Rotolo MC; Giorgetti R; Tagliabracci A; Busardò FP; Huestis MA
Clin Chem Lab Med; 2020 Apr; 58(5):682-689. PubMed ID: 30956228
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users.
Wille SM; Di Fazio V; Toennes SW; van Wel JH; Ramaekers JG; Samyn N
Drug Test Anal; 2015 Mar; 7(3):178-86. PubMed ID: 24753449
[TBL] [Abstract][Full Text] [Related]
57. Identification and quantification of cannabinoids in postmortem fluids and tissues by liquid chromatography-tandem mass spectrometry.
Cliburn KD; Huestis MA; Wagner JR; Kemp PM
J Chromatogr A; 2021 Aug; 1652():462345. PubMed ID: 34198104
[TBL] [Abstract][Full Text] [Related]
58. Determination of cannabinoids in oral fluid and urine of "light cannabis" consumers: a pilot study.
Pacifici R; Pichini S; Pellegrini M; Tittarelli R; Pantano F; Mannocchi G; Rotolo MC; Busardò FP
Clin Chem Lab Med; 2018 Dec; 57(2):238-243. PubMed ID: 30332386
[TBL] [Abstract][Full Text] [Related]
59. Determination of Cannabinoids in Breast Milk Using QuEChERS and Ultra-Performance Liquid Chromatography and Tandem Mass Spectrometry.
Ramnarine RS; Poklis JL; Wolf CE
J Anal Toxicol; 2019 Oct; 43(9):746-752. PubMed ID: 31436289
[TBL] [Abstract][Full Text] [Related]
60. Detection of cannabis in oral fluid (saliva) and forehead wipes (sweat) from impaired drivers.
Kintz P; Cirimele V; Ludes B
J Anal Toxicol; 2000 Oct; 24(7):557-61. PubMed ID: 11043659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
